AlveoliX AG

<p>AlveoliX aims at changing classical drug development by providing advanced<br /> in-vitro models that reproduce the in-vivo environment in an unprecedented<br /> manner. By doing so, we want to make organs-on-chip technology the new<br /> standard for preclinical decision-making.<br /> Our easy-to-use 3D culture models provide the essential know-how and inspiration to<br /> design better and safer drugs. At the same time, they allow researchers to<br /> investigate and understand critical cellular pathways more accurately by including<br /> the breathing function to simulate the micro-environment of the lung, allowing to<br /> recreate healthy, diseased, and personalized models to test molecule safety (drugs,<br /> pollutants, cosmetics, etc.) and drug efficacy as an alternative to animal models. </p> <p>www.alveolix.com<br /> https://www.linkedin.com/company/alveolix</p>